معرفی
Meghan Van Zandt is an Associate Research Scientist in the Department of Psychiatry at the Yale School of Medicine, Yale University. Her research focuses on RNA biology, drug discovery, and cancer therapeutics, particularly involving the development of inhibitors targeting RNA splicing mechanisms and cancer-associated enzymes like CD73.
Key contributions include:
- Development of quinazoline derivatives inhibiting fungal group II introns
- Discovery of nucleoside inhibitors of CD73 showing antitumor activity
Her work bridges chemical biology and medicinal chemistry, with applications in understanding fungal pathogenesis and cancer treatment.
۰مقاله منتشرشده
